Search Ontology:
ChEBI
prostaglandin E2
- Term ID
- CHEBI:15551
- Synonyms
-
- (15S)-prostaglandin E2
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
- (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
- (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
- (Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
- Cervidil
- Cerviprime
- Cerviprost
- Dinoproston
- dinoprostona
- dinoprostone
- dinoprostonum
- Enzaprost E
- Glandin-E2
- Minprositin E2
- Minprostin E2
- PGE2
- Prepidil
- Propess
- Prostaglandin E2
- Prostarmon E
- Prostenone
- Prostin
- Prostin E2
- U 12062
- U-12,062
- U-12062
- Definition
- Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
- References
-
- Beilstein:2224724
- CAS:363-24-6
- DrugBank:DB00917
- Drug_Central:913
- FooDB:FDB022498
- HMDB:HMDB0001220
- KEGG:C00584
- KEGG:D00079
- LINCS:LSM-42919
- LIPID_MAPS_instance:LMFA03010003
- PDBeChem:P2E
- PMID:11279302
- PMID:12746806
- PMID:12859290
- PMID:14499495
- PMID:14535055
- PMID:14703707
- PMID:15542928
- PMID:15661432
- PMID:16405508
- PMID:16787416
- PMID:16978535
- PMID:20671299
- PMID:2403792
- PMID:24501112
- PMID:32898608
- PMID:33271839
- PMID:33559528
- PMID:33685091
- PMID:33715333
- PMID:33782420
- PMID:33811074
- PMID:33958485
- PMID:34065827
- PMID:34071686
- PMID:34102274
- PMID:6317292
- PMID:7224729
- PMID:74611
- PMID:7836930
- PMID:9276764
- Patent:DE2011969
- Patent:GB851827
- Patent:NL6505799
- Patent:US3598858
- Reaxys:2224724
- Wikipedia:Prostaglandin_E2
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_functional_parent
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Phenotype
Phenotype resulting from prostaglandin E2
Phenotype where environments contain prostaglandin E2
Phenotype modified by environments containing prostaglandin E2
Human Disease Model